📰 Robert Pryde News
Page 2 - Robert Pryde News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Robert Pryde. Real-time updates on events, politics, business and more.
November 30, 2023
-Samples up to 25.60 g/t Au at Surface- BMEX Gold Inc. announces results from a highly successful 2023 surface exploration program at Dunlop Bay, , with up to 25.6 g/t Au and three new gold zone discoveries that are open in all directions. The 2023... - Veroeffentlicht am 30.11.2023
November 30, 2023
Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.
October 26, 2023
BMEX Gold Inc. announces that due to current market conditions, it will not be proceeding with its non-brokered private placement of units and flow-through shares previously announced on August 29,...
September 6, 2023
Gold Stock News - BMEX Gold (TSXV: BMEX) Announces Fall Exploration Program Targeting Precious Metal Rich VMS At Dunlop Bay, Quebec
December 30, 2022
Vancouver, British Columbia--(Newsfile Corp. - December 30, 2022) - BMEX Gold Inc. (TSXV: BMEX) (OTCQB: MRIRF) (FSE: 8M0) ("BMEX" or the "Company") is pleased to announce it has closed its previously
December 21, 2022
Vancouver, British Columbia--(Newsfile Corp. - December 21, 2022) - BMEX Gold Inc. (TSXV: BMEX) (OTCQB: MRIRF) (FSE: 8M0) ("BMEX" or the "Company") is pleased to announce a private placement of up to
October 25, 2022
Vancouver, British Columbia--(Newsfile Corp. - October 25, 2022) - BMEX Gold Inc. (TSXV: BMEX) (OTCQB: MRIRF) (FSE: 8M0) ("BMEX" or the "Company") is pleased to discuss the visual results of the first
July 7, 2022
Vancouver, British Columbia--(Newsfile Corp. - July 7, 2022) - BMEX Gold Inc. (TSXV: BMEX) (OTCQB: MRIRF) (FSE: 8M0) ("BMEX" or the "Company") is pleased to announce the final interpretation of a ground
July 7, 2022
Lobe Sciences Ltd has announced the development of its initial Phase 1 study plan to demonstrate the safety and appropriate dosing range for its proprietary...
July 7, 2022
Lobe Sciences Ltd has announced the development of its initial Phase 1 study plan to demonstrate the safety and appropriate dosing range for its proprietary...